TraceLink, based in Wakefield, Mass., has raised $20 million in funding, according to a Pulse 2.0 report.
TraceLink provides patient safety solutions. The new venture funding was led by Volition Capital with participation from Fidelity Biosciences and FirstMark Capital.
TraceLink has a supply chain network of more than 80,000 manufacturers, distributors, repackagers, pharmacies and healthcare practitioners, according to the report.